Consolidated Statement Of Income

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7547517

Concept 2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2023-04-01 to
2023-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
Consolidated statement of income
Statement of income
Net sales
605,000,000 JPY
18,150,000,000 JPY
17,545,000,000 JPY
18,150,000,000 JPY
JPY
615,000,000 JPY
17,582,000,000 JPY
18,197,000,000 JPY
JPY
18,197,000,000 JPY
Cost of sales
8,094,000,000 JPY
8,157,000,000 JPY
Operating expenses
Selling, general and administrative expenses
6,762,000,000 JPY
5,983,000,000 JPY
Other
2,379,000,000 JPY
2,153,000,000 JPY
Operating expenses
Ordinary profit (loss)
3,488,000,000 JPY
4,332,000,000 JPY
Operating profit (loss)
321,000,000 JPY
3,293,000,000 JPY
2,972,000,000 JPY
3,293,000,000 JPY
JPY
295,000,000 JPY
3,760,000,000 JPY
4,056,000,000 JPY
JPY
4,056,000,000 JPY
Net sales
Operating expenses
Research and development expenses
2,600,000,000 JPY
2,030,000,000 JPY
Gross profit (loss)
10,056,000,000 JPY
10,040,000,000 JPY
Cost of sales
Selling, general and administrative expenses
Salaries
1,417,000,000 JPY
1,407,000,000 JPY
Non-operating income
Interest income
2,000,000 JPY
1,000,000 JPY
Dividend income
247,000,000 JPY
229,000,000 JPY
Other
7,000,000 JPY
50,000,000 JPY
Non-operating income
256,000,000 JPY
281,000,000 JPY
Extraordinary income
0 JPY
0 JPY
Other
0 JPY
0 JPY
Extraordinary losses
38,000,000 JPY
324,000,000 JPY
Impairment losses
JPY
304,000,000 JPY
Other
0 JPY
JPY
Non-operating expenses
Interest expenses
4,000,000 JPY
4,000,000 JPY
Other
5,000,000 JPY
1,000,000 JPY
Non-operating expenses
61,000,000 JPY
5,000,000 JPY
Profit (loss) before income taxes
3,451,000,000 JPY
4,008,000,000 JPY
Gross profit
Extraordinary income
Extraordinary losses
Loss on retirement of non-current assets
37,000,000 JPY
19,000,000 JPY
Income taxes
940,000,000 JPY
1,100,000,000 JPY
Profit (loss)
2,510,000,000 JPY
2,907,000,000 JPY
Profit (loss) attributable to non-controlling interests
JPY
JPY
Profit (loss) attributable to owners of parent
2,510,000,000 JPY
2,907,000,000 JPY
Profit attributable to
Other comprehensive income
Valuation difference on available-for-sale securities
1,301,000,000 JPY
90,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-1,000,000 JPY
15,000,000 JPY
Other comprehensive income
1,300,000,000 JPY
106,000,000 JPY
Comprehensive income
3,810,000,000 JPY
3,014,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
3,810,000,000 JPY
3,014,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.